- Open Access
Management of leiomyosarcomas of the spermatic cord: the role of reconstructive surgery
© Enoch et al; licensee BioMed Central Ltd. 2005
Received: 23 January 2005
Accepted: 28 April 2005
Published: 28 April 2005
Leiomyosarcomas (LMS) of the spermatic cord are extremely rare. Radical inguinal orchiectomy and high ligation of the cord is the standard primary surgical procedure. The extent of surrounding soft tissue excision required and the precise role of adjuvant radiotherapy, however, remains unclear. In addition, recurrence is a commonly encountered problem which might necessitate further radical excision of adjacent soft tissues.
This article reviews the pathophysiology of spermatic cord leiomyosarcomas (LMS), and discusses the various reconstructive surgical options available to repair the inguinal region and the lower anterior abdominal wall after excision of the tumour and the adjacent soft tissues.
There is paucity of literature on LMS of spermatic cord. The majority of paratesticular neoplasms are of mesenchymal origin and up to 30% of these are malignant. In adults, approximately 10% of spermatic cord sarcomas are LMS. Approximately 50% of these tumours recur loco-regionally following definitive surgery; however, the incidence decreases if resection is followed by adjuvant radiotherapy.
It is therefore important to achieve negative histological margins during the primary surgical procedure, even if adjuvant radiotherapy is instituted. If extensive resection is required, either during the primary procedure or following recurrence, reconstructive surgery may become necessary. This article reviews the pathophysiology of spermatic cord LMS, the reasons for recurrence, and discusses the management options including the role of reconstructive surgery.
Tumours of the spermatic cord and paratesticular tissue are rare [1, 2], and as such, their true incidence has never been established. Radical inguinal orchiectomy and high ligation of the cord is the standard primary surgical procedure. However, the extent of surrounding soft tissue excision required, including margins, and the role of adjuvant radiotherapy (RT), remains controversial. The paucity of literature in this area often makes treatment decisions difficult; prospective trials are precluded by the rarity of this tumour and no series is sufficiently large to accurately evaluate the most appropriate treatment option.
Recurrence is a commonly encountered problem, which might necessitate further radical excision of adjacent soft tissues. It hence becomes important to achieve negative histological margins during the primary surgery even if adjuvant radiotherapy (RT) is instituted. If extensive areas of adjacent soft tissues are resected, either during the primary procedure or following recurrence, reconstructive surgery may be indicated to repair the defect.
In addition to debating the above issues, this article reviews the pathophysiology of spermatic cord leiomyosarcomas (LMS), and discusses the various reconstructive surgical options available to repair the inguinal region and the lower anterior abdominal wall after excision of the tumour and the adjacent soft tissues.
The majority of paratesticular neoplasms are of mesenchymal origin and up to 30% of these are malignant . In adults, approximately 10% of spermatic cord sarcomas are LMS with a peak incidence in the sixth and seventh decades . LMS most likely originate from the smooth muscle of different areas such as the vas deference canal wall, blood vessels and cremaster muscle, and is thought to arise as a result of malignant degeneration from previously existing leiomyomatous tumours .
It has been estimated that approximately 50% of these tumours recur loco-regionally following definitive surgery [6–10], although the incidence decreases if resection is followed by adjuvant RT [8, 9]. Pathologic features that convey a higher risk of local recurrence include large tumour size, inguinal location, narrow or positive margins and prior intralesional surgery . Loco-regional relapse may occur in the cord, scrotum, or adjacent pelvis, with or without involvement of the regional lymph nodes . If relapse occurs in the cord or scrotum, they often extend proximally through the internal inguinal ring into the pelvic cavity .
The patients may also present with signs and symptoms of distant metastasis, although dissemination may be seen as late as 15 or more years after resection of the primary tumour . The common means of metastasis are by lymphatic spread either to the regional (pelvic)  or distant lymph nodes (para-aortic) , and by the haematogenous route, usually to the lungs and the liver [9, 12]; metastasis to other regions such as the orbit , although rare, may also occur.
Preoperative diagnosis of spermatic cord LMS is difficult and the tumour is usually described as a firm, gradually enlarging, and painless extra-testicular intra-scrotal mass . It may be occasionally accompanied by a hydrocoele . Scrotal ultrasound is a useful initial investigation to identify a sinister mass within the scrotum . If a neoplasm is identified, magnetic resonance imaging is the investigation of choice to characterise and delineate the anatomical extent of the tumour . Other modalities such as fluorodeoxyglucose positron emission tomography (FDG-PET) have been used in the diagnosis of dedifferentiated liposarcoma of the spermatic cord ; but it is not established in routine clinical practice. The role, if any, of fine needle aspiration cytology in the preoperative diagnosis of spermatic cord LMS has not been clearly established although they have been used to diagnose other types of spermatic cord sarcomas such as liposarcoma  and malignant fibrous histiocytoma [21, 22].
Surgical excision and margins
Radical inguinal orchiectomy and high ligation of the cord is the standard primary surgical procedure [9, 23, 24]. The extent of surrounding soft tissue excision and the margins required, however, remains controversial. Simple excision is clearly inadequate for paratesticular sarcomas as repeat wide excision has revealed microscopic residual disease in 27% of completely excised cases . Aggressive surgical strategies are therefore recommended in the management of spermatic cord LMS and a decrease in local recurrence has been observed in patients who underwent re-operative wide excision after a prior incomplete resection .
Malignant mesenchymal tumours such as LMS have a "pseudocapsule"  and, as such, there may be infiltration of tumour cells into the adjacent tissues; therefore, it might be difficult to precisely estimate the tumour margins. Due to this 'irregular' pattern of tumour growth and the anatomical constraints in the inguinal region, wide circumferential resection margins may be difficult to achieve [1, 12]. Nevertheless, due to the tumours' high propensity for local recurrence, if negative histological margins are not achieved during primary surgery, re-excision should be considered mandatory, even if this involves sacrificing some areas of adjacent normal anatomy. Advances in microsurgery have made it possible to reconstruct significant anatomical defects in this region (discussed later).
The role of prophylactic lymph node dissection remains unclear. Although performed in some centres, the true incidence of para-aortic and pelvic nodal metastasis has never been documented , and hence there is insufficient evidence at present to suggest that prophylactic para-aortic and pelvic nodal dissection prevents relapse or improves the prognosis of patients with spermatic cord LMS . It, however, has a role in other types of para-testicular sarcomas such as rhabdomyosarcomas, fibrosarcomas, and intermediate or high-grade malignant fibrous histiocytomas .
Surgically relevant anatomy
The inguinal canal allows the passage of the spermatic cord or round ligament (in females) without vascular compromise and without obstructing ductus deferens in the male. Below the inguinal ligament lies the femoral triangle. The boundaries of the femoral triangle are the inguinal ligament superiorly, the medial border of sartorius laterally, and the medial border of adductor longus medially. The femoral triangle contains the femoral vessels and nerve, sapheno-femoral junction and the deep inguinal lymph nodes.
Reconstruction of the inguinal region and the anterior lower abdominal wall after wide surgical resection
reconstructive surgical options to cover defects in the inguinal region and the anterior lower abdominal wall
Name of flap
Skin and fat flap
• Deep inferior epigastric perforator (DIEP) flap
• Antero – lateral thigh flap
• Groin flap
• Rectus abdominis flap (TRAM/VRAM)
• Tensor fasciae latae flap
• Gracilis flap
• Rectus femoris flap
• Vastus lateralis flap
• Latissimus dorsi flap
• Sartorius muscle switch
• Omental flap
If the resection is not deep (no muscle loss), fascio-cutaneous flaps such as the groin flap and the antero-lateral thigh flap, or an abdominal wall skin and fat flap based on perforating vessels – deep inferior epigastric perforator (DIEP) flap – could be used. The use of a groin flap, however, may be limited in situations where the vessels, which originate in the femoral triangle, may be ligated as part of the resection. If femoral dissection is required leading to soft tissue loss, a sartorius muscle switch or an omental flap  could be used to cover exposed vessels in the femoral triangle.
In the event of no local flap options being available (very rare), a free flap may be used to achieve cover. This involves raising a distant flap, usually the latissimus dorsi muscle, disconnecting the blood supply and transferring the tissue to the groin and anastomosing the thoraco-dorsal vessels to recipient vessels in the inguinal region.
The use of well vascularised tissue to cover exposed femoral vessels is important as it minimises local vascular complications when adjuvant RT is instituted to the groin region.
The various reconstructive options discussed above are useful in different clinical (or operative) scenarios. With adequate planning and proper choice, satisfactory short- and long-term results can be obtained with all the above reconstructive procedures. The choice of one particular flap for reconstruction depends on various factors: (i) the anatomical location of the cover required; (ii) the extent and type of soft tissue loss (e.g., skin, muscle, etc.); (iii) tumour type – primary or recurrent; (iv) the ease of donor site coverage; (v) flap availability; and (vi) the experience of the surgeon in the usage of a particular flap. In primary tumours, the skin might not be involved and hence a muscle flap might be adequate. However, in recurrence, the overlying skin might be damaged due to RT. This may necessitate excision of the skin (along with underlying tissues) and coverage using a musculo-cutaneous or a fascio-cutanoeus flap (alternatively a muscle flap with split skin grafting can be used).
Radiotherapy and chemotherapy
Adjuvant RT has become an established method in the management of LMS of the spermatic cord [8, 9, 12, 13]. Some authors recommend adjuvant RT only for high-grade LMS or to those patients believed to be at a high risk of local recurrence. However, due to the tumour's high propensity (approximately 50%) [8, 9] of local recurrence following surgery alone [6, 12], there is increasing consensus that LMS of all grades and histology should receive adjuvant RT . Several studies have reported better results with combined modality treatment and the recurrence could be reduced to 10 – 20% by using adjuvant RT . It needs to be emphasised at this point that adjuvant RT should supplement rather than substitute radical surgical excision and should be instituted only after complete clearance of the tumour is achieved surgically. The field for RT should include the inguinal canal, ipsilateral pelvic tissue , and the scrotum . The role of pre-operative RT has not been clearly established, and, as such, there is no evidence to suggest that radiotherapy before surgical excision reduces the rate of recurrence or improves the overall prognosis.
There are no controlled studies at present that specifically addresses the role of adjuvant systemic chemotherapy in adult spermatic cord LMS , although they have a well-defined role in childhood rhabdomyosarcomas . Adjuvant chemotherapy is currently not used routinely in the management of spermatic cord LMS though it has been suggested that it might have a role in abrogating the haematogenous metastatic potential in high grade sarcomas  and in patients with metastatic disease.
The prognosis of patients with LMS is highly variable. Kyle (1966)  suggested a probable five-year survival of 10–15% but more recently a five-year survival of 50–80% has been reported , possibly reflecting the advances in diagnosis and management of these tumours. The wide range in the five-year survival rate might be due to the variations in tumour stage and grade at the time of diagnosis as well as the diversity of therapies involved.
In the management of spermatic cord LMS, complete excision of the tumour with radical inguinal orchiectomy and high ligation of the cord should be the primary surgical procedure. Due to the high propensity for local recurrence, if the margins are not clear, re-excision should be considered in all cases. In addition, based on current evidence, the authors recommend that adjuvant RT should be instituted for all grades and types of spermatic cord LMS. There is insufficient evidence to advocate prophylactic nodal treatment in the management of these tumours.
- Lioe TF, Biggart JD: Tumours of the spermatic cord and paratesticular tissue. A clinicopathologic study. Br J Urol. 1993, 71: 600-606.View ArticlePubMedGoogle Scholar
- Donovan MG, Fitzpatrick JM, Gaffney EF: Paratesticular leiomyosarcoma. Br J Urol. 1987, 60: 590View ArticlePubMedGoogle Scholar
- Bajaj P, Agarwal K, Niveditha SR, Pathania OP: Leiomyosarcoma arising from tunica vaginalis testis: a case report. Indian J Pathol Microbiol. 2001, 44: 145-146.PubMedGoogle Scholar
- Rao CR, Srinivasulu M, Naresh KN, Doval DC, Hazarika D: Adult Paratesticular Sarcomas: A report of eight cases. J Surg Oncol. 1994, 56: 89-93.View ArticlePubMedGoogle Scholar
- Padilla AJ, Gonzalez CM, Caldero MM, Arano YA, Torroella BF, Fanlo AP: Leiomyosarcoma of the spermatic cord. Actas Urol Esp. 1993, 17: 464-467.Google Scholar
- Blitzer PH, Dozoretz DE, Proppe KH: Treatment of malignant tumours of the spermatic cord: A study of 10 cases and review of the literature. J Urol. 1981, 126: 611-614.PubMedGoogle Scholar
- Sclama AO, Berger BW, Cherry JM, Young JD: Malignant fibrous histiocytoma of the spermatic cord: the role of retroperitoneal lymphadenectomy in management. J Urol. 1983, 130: 577-579.PubMedGoogle Scholar
- Catton CN, Cummings BJ, Fornasier V, O'Sullivan B, Quirt I, Warr D: Adult paratesticular sarcomas: a review of 21 cases. J Urol. 1991, 146: 342-345.PubMedGoogle Scholar
- Fagundes MA, Zietman AL, Althausen AF, Coen JJ, Shipley WU: The management of spermatic cord sarcoma. Cancer. 1996, 77: 1873-1876. 10.1002/(SICI)1097-0142(19960501)77:9<1873::AID-CNCR17>3.0.CO;2-X.View ArticlePubMedGoogle Scholar
- Merimsky O, Terrier P, Bonvalot S, Le Pechoux C, Delord JP, Le Cesne A: Spermatic cord sarcomas in adults. Acta Oncologica. 1999, 38: 635-638. 10.1080/028418699431249.View ArticlePubMedGoogle Scholar
- Folpe AL, Weiss SW: Paratesticular soft tissue neoplasms. Semin Diagn Pathol. 2000, 17: 307-318.PubMedGoogle Scholar
- Ballo MT, Zagars GK, Pisters PW, Le Pechoux C, Delord JP, Le Cesne A: Spermatic cord sarcoma: outcome, patterns of failure, and management. J Urol. 2001, 166: 1306-1310. 10.1097/00005392-200110000-00019.View ArticlePubMedGoogle Scholar
- Schiller AL, Teitelbaum SL: Smooth muscle tumours. Pathology. Edited by: Rubin E, Farber JL. 1999, Lippincort-Raven publishers, Philadelphia, 1411-thirdGoogle Scholar
- Banowsky LH, Shultz GN: Sarcoma of the spermatic cord and tunics: review of the literature, case report and discussion of the role of retroperitoneal lymph node dissection. J Urol. 1970, 103: 628-631.PubMedGoogle Scholar
- Bakri SJ, Krohel GB, Peters GB, Farber MG: Spermatic cord leiomyosarcoma metastatic to the orbit. Am J Ophthalmol. 2003, 136: 213-215. 10.1016/S0002-9394(02)02279-1.View ArticlePubMedGoogle Scholar
- Stein A, Kaplun A, Sova Y, Zivan I, Laver B, Lurie M, Lurie A: Leiomyosarcoma of the spermatic cord: report of two cases and review of the literature. World J Urol. 1996, 14: 59-61.View ArticlePubMedGoogle Scholar
- Secil M, Kefi A, Gulbahar F, Aslan G, Tuna B, Yorukoglu K: Sonographic features of spermatic cord leiomyosarcoma. J Ultrasound Med. 2004, 23: 973-976.PubMedGoogle Scholar
- Woodward PJ, Schwab CM, Sesterhenn IA: From the archives of the AFIP: Extratesticular scrotal masses: radiologic-pathologic correlation. Radiographics. 2003, 23: 215-240.View ArticlePubMedGoogle Scholar
- Kosuda S, Wahl RL, Grossman HB: Demonstration of recurrent dedifferentiated liposarcoma of the spermatic cord by FDG-PET. Ann Nucl Med. 1997, 11: 263-266.View ArticlePubMedGoogle Scholar
- Dalla Palma P, Barbazza R: Well-differentiated liposarcoma of the paratesticular area: report of a case with fine-needle aspiration preoperative diagnosis and review of the literature. Diagn Cytopathol. 1990, 6: 421-426.View ArticlePubMedGoogle Scholar
- Bosch-Princep R, Martinez-Gonzalez S, Alvaro-Naranjo T, Castellano-Megias VM, Salvado-Usach MT, Marti-Mestre J: Fine needle aspiration and touch imprint cytology of a malignant fibrous histiocytoma of the spermatic cord: case report. Acta Cytol. 2000, 44: 423-428.View ArticlePubMedGoogle Scholar
- Berardo MD, Powers CN, Wakely PE, Almeida MO, Frable WJ: Fine-needle aspiration cytopathology of malignant fibrous histiocytoma. Cancer. 1997, 81: 228-237. 10.1002/(SICI)1097-0142(19970825)81:4<228::AID-CNCR5>3.0.CO;2-L.View ArticlePubMedGoogle Scholar
- Catton C, Jewett M, O'Sullivan B, Kandel R: Paratesticular sarcoma: failure patterns after definitive local therapy. J Urol. 1999, 161: 1844-1847. 10.1097/00005392-199906000-00033.View ArticlePubMedGoogle Scholar
- Watanabe J, Soma T, Kawa G, Hida S, Koisi M: Leiomyosarcoma of the spermatic cord. Int J Urol. 1999, 6: 536-538. 10.1046/j.1442-2042.1999.00100.x.View ArticlePubMedGoogle Scholar
- Coleman J, Brennan MF, Alektiar K, Russo P: Adult spermatic cord sarcomas: management and results. Ann Surg Oncol. 2003, 10: 669-675. 10.1245/ASO.2003.11.014.View ArticlePubMedGoogle Scholar
- Bowden L, Booher RJ: The principles and technique of resection of soft parts for sarcoma. Surgery. 1958, 44: 963-977.PubMedGoogle Scholar
- Roth DA: Thoracic and abdominal wall reconstruction. Grabb and Smith's Plastic Surgery. Edited by: Aston SJ, Beasley RW. 1997, Thorne CHM. Lippincott-Raven publishers, Philadelphia, 1029-FifthGoogle Scholar
- Watkins RM, Thomas JM: The role of greater omentum in reconstructing skin and soft tissue defects of the groin and axilla. Br J Surg. 1985, 72: 925-926.View ArticlePubMedGoogle Scholar
- Tran LM, Mark R, Meier R, Calcattera TC, Parker RG: Sarcoma of the head and neck. Cancer. 1992, 70: 169-177.View ArticlePubMedGoogle Scholar
- de Vries JD: Paratesticular rhabdomyosarcoma. World J Urol. 1995, 13: 219-225.View ArticlePubMedGoogle Scholar
- Kyle VN: Leiomyosarcoma of the spermatic cord: a review of the literature and report of an additional case. J Urol. 1966, 96: 795-PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.